PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.20−0.12 (-9.09%)
Close on Nov 19, 2026Market cap $9.60MP/E –Yield –
PAVmed net income
Net income is the profit left for shareholders after every expense, interest and tax.
PAVmed's net income for the twelve months ending Jun 30, 2026 was -$12.09M, down 116.6% year over year. For fiscal 2025 it was $401.00K, down 99.0% from the year before. The highest annual figure on record is $39.79M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $401.00K | -99.0% |
| FY2024 | Dec 31, 2024 | $39.79M | – |
| FY2023 | Dec 31, 2023 | -$64.18M | – |
| FY2022 | Dec 31, 2022 | -$88.98M | – |
| FY2021 | Dec 31, 2021 | -$50.35M | – |
| FY2020 | Dec 31, 2020 | -$34.28M | – |
| FY2019 | Dec 31, 2019 | -$16.46M | – |
| FY2018 | Dec 31, 2018 | -$17.97M | – |
| FY2017 | Dec 31, 2017 | -$9.52M | – |
| FY2016 | Dec 31, 2016 | -$5.65M | – |
| FY2015 | Dec 31, 2015 | -$1.78M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.38M | – |
| Q1 FY2026 | Mar 31, 2026 | -$60.00K | -100.3% |
| Q4 FY2025 | Dec 31, 2025 | -$1.26M | -188.3% |
| Q3 FY2025 | Sep 30, 2025 | -$5.38M | -108.4% |
| Q2 FY2025 | Jun 30, 2025 | -$11.92M | – |
| Q1 FY2025 | Mar 31, 2025 | $18.97M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.43M | – |
| Q3 FY2024 | Sep 30, 2024 | $64.40M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.04M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.67M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.54M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.93M | – |
| Q4 FY2022 | Dec 31, 2022 | -$20.46M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.13M | – |
| Q2 FY2022 | Jun 30, 2022 | -$25.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.23M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.47M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.74M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.58M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.48M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.24M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.59M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.54M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.83M | -885.4% |
| Q3 FY2018 | Sep 30, 2018 | -$3.25M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.07M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.83M | – |
| Q4 FY2017 | Dec 31, 2017 | $869.84K | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.13M | – |
| Q2 FY2017 | Jun 30, 2017 | -$989.71K | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.27M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.71M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.93M | – |
See a number that looks wrong?